Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-04-04

Clinical Trial Update: Efficacy and Safety of Fuke Qianjin Capsule in Patients With Pelvic Inflammatory Diseases [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating efficacy and safety of Fuke Qianjin Capsule in pelvic inflammatory disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FuKe Qianjin Capsule

Snippet

Sponsor: University of Karachi | Conditions: Pelvic Inflammatory Disease | Phase 2 | Status: COMPLETED